Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Colorcon
Accenture
Boehringer Ingelheim
Moodys
Citi
Covington
UBS
Cerilliant
Argus Health

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075706

« Back to Dashboard

NDA 075706 describes LORATADINE AND PSEUDOEPHEDRINE SULFATE, which is a drug marketed by Actavis Labs Fl Inc, Perrigo Pharma Intl, and Sun Pharm Inds Ltd, and is included in five NDAs. It is available from forty-four suppliers. Additional details are available on the LORATADINE AND PSEUDOEPHEDRINE SULFATE profile page.

The generic ingredient in LORATADINE AND PSEUDOEPHEDRINE SULFATE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 075706
Tradename:LORATADINE AND PSEUDOEPHEDRINE SULFATE
Applicant:Actavis Labs Fl Inc
Ingredient:loratadine; pseudoephedrine sulfate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 075706
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LORATADINE AND PSEUDOEPHEDRINE SULFATE loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 075706 ANDA L Perrigo Company 0113-1165 0113-1165-52 2 BLISTER PACK in 1 CARTON (0113-1165-52) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
LORATADINE AND PSEUDOEPHEDRINE SULFATE loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 075706 ANDA L Perrigo Company 0113-1165 0113-1165-22 3 BLISTER PACK in 1 CARTON (0113-1165-22) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength10MG;240MG
Approval Date:Feb 21, 2003TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Accenture
Cipla
Healthtrust
Farmers Insurance
US Army
Fuji
Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot